CAR-T-ICI: COMBINATION OF CHIMERIC ANTIGEN RECEPTOR T-CELL WITH ANTI PD-1 IMMUNE CHECKPOINT INHIBITOR AS A NOVEL TREATMENT FOR COLORECTAL CANCER: Combination of Chimeric Antigen Receptor T-Cell With Anti PD-1 Immune Checkpoint Inhibitor As a Novel Treatment for Colorectal Cancer. JIMKI 2021, 9 (1), 56-68. https://doi.org/10.53366/jimki.v9i1.339.